Varian unveils Trilogy system at cancer center in France
The Georges-François Leclerc Cancer Center in Dijon, France, has installed a Trilogy linear accelerator from Varian Medical Systems to give patients with cancer access to image-guided radiotherapy treatments.
The Trilogy device becomes the hospital’s third Varian linear accelerator, enabling the center to treat more patients with more advanced treatments, including stereotactic radiosurgery, according to the Palo Alto, Calif.-based Varian.
“The Trilogy enables us to carry out very precise image-guided stereotactic treatments in addition to our established program of intensity-modulated radiotherapy (IMRT) treatments,” said professor Philippe Maingon, MD. “This is an important step forward in bringing advanced and targeted radiotherapy to patients in this location.”
Maingon said his team will begin using the Trilogy for prostate cancer treatments, using the cone-beam CT imaging capabilities to validate the accuracy of patient set-up positioning prior to treatment in a dose escalation program. Doctors will also use the new machine to take part in a national hypo-fractionation clinical research trial involving hypo-fractionated stereotactic treatment of lung tumors, Varian said.
The Georges-François Leclerc Cancer Center, which treats 1200 patients each year and serves cancer patients within 200 kilometers, has been one of two hospitals to host Varian’s European IMRT School in recent years.
The Trilogy device becomes the hospital’s third Varian linear accelerator, enabling the center to treat more patients with more advanced treatments, including stereotactic radiosurgery, according to the Palo Alto, Calif.-based Varian.
“The Trilogy enables us to carry out very precise image-guided stereotactic treatments in addition to our established program of intensity-modulated radiotherapy (IMRT) treatments,” said professor Philippe Maingon, MD. “This is an important step forward in bringing advanced and targeted radiotherapy to patients in this location.”
Maingon said his team will begin using the Trilogy for prostate cancer treatments, using the cone-beam CT imaging capabilities to validate the accuracy of patient set-up positioning prior to treatment in a dose escalation program. Doctors will also use the new machine to take part in a national hypo-fractionation clinical research trial involving hypo-fractionated stereotactic treatment of lung tumors, Varian said.
The Georges-François Leclerc Cancer Center, which treats 1200 patients each year and serves cancer patients within 200 kilometers, has been one of two hospitals to host Varian’s European IMRT School in recent years.